Botulinum Toxin A for bruxism: a systematic review
DOI:
https://doi.org/10.5935/0104-7795.20140039Keywords:
Botulinum Toxins, Type A, Bruxism, Pain, RehabilitationAbstract
Objective: To systematize the scientific evidence on the efficacy of botulinum toxin type A in the treatment of bruxism. Method: A bibliographical search was made by researching the PubMed Central Journals and Allergan Products Literature (APL) - botulinum toxin within the last 10 years, with the following descriptors: “bruxism,” “botulinum toxin,” and “treatment”. The methodological quality of the studies was evaluated by the Jadad Scale. Results: Two studies of double blind randomized clinical trials were selected. The two clinical studies showed that the application of botulinum toxin could diminish levels of pain, lower the frequency of occurrences of bruxism, and satisfy the patients in terms of efficacy of the botulinum toxin in this pathology, in addition to having no important adverse effects. Thus, the treatment with botulinum toxin type A could present itself as one possible treatment for patients with bruxism. Conclusion: More studies are needed that follow the quality criteria to reach a definitive conclusion about efficacy and safety.
Downloads
References
Biasotto-Gonzalez DA. Abordagem interdisciplinar das disfunções temporomandibulares. Barueri: Manole; 2005.
Maciel RN. Hipóteses etiólicas. In: Maciel RN. Bruxismo. São Paulo: Artes Médicas; 2010. p. 5-42.
Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil. 2010;89(1):16-23. DOI: http://dx.doi.org/10.1097/PHM.0b013e3181bc0c78
Faot F, Custódio LG, Melo ACM, Hermann C. Bruxismo - Parte 1. J ILAPEO. 2008;1(1):12-6.
Bhidayasiri R, Cardoso F, Truong DD. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. Eur J Neurol. 2006;13 Suppl 1:21-9. DOI: http://dx.doi.org/10.1111/j.1468-1331.2006.01441.x
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
Alonso-Navarro H, Jiménez-Jiménez FJ, Plaza-Nieto JF, Pilo-De la Fuente B, Navacerrada F, Arroyo-Solera M, et al. Treatment of severe bruxism with botulinum toxin type A. Rev Neurol. 2011;53(2):73-6.
Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio. 2008;26(2):126-35.
Redaelli A. Botulinum Toxin A in bruxers. One year experience. Saudi Med J. 2011;32(2):156-8.
Sener HO, Oral N, Key F. Intramasseteric botulinum toxin injection is as effective as oral overnight splint in nocturnal bruxism. Cephalalgia 2007; 27(10):1191
Bolayir G, Bolayir E, Coskun A, Ozdemir AK, Topakta S. Botulinum toxin type A. Practice in bruxism cases. Neurol Psychiat Br. 2005;12(1):43-5.
Manfredini D, Lobbezoo F. Relationship between bruxism and temporomandibular disorders: a systematic review of literature from 1998 to 2008. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(6):e26-50. DOI: http://dx.doi.org/10.1016/j.tripleo.2010.02.013
American Academy of Sleep Medicine. International classification of sleep disorders. 2nd ed. Rochester; Allen Press; 2005.
Murshed N, Dakka Y, Angus E. Successful Treatment of severe bruxism with onabotulinum toxin A in patients with post anoxic brain injury. Neurology.2012;78(-Meeting Abstracts 1):P01.237. DOI: http://dx.doi.org/10.1212/WNL.78.1_MeetingAbstracts.P01.237
Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785-93. DOI: http://dx.doi.org/10.1016/j.neuro.2005.01.017
Long H, Liao Z, Wang Y, Liao L, Lai W. Efficacy of botulinum toxins on bruxism: an evidence-based review. Int Dent J. 2012;62(1):1-5. DOI: http://dx.doi.org/10.1111/j.1875-595X.2011.00085.x
Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg. 2008;66(8):1644-51. DOI: http://dx.doi.org/10.1016/j.joms.2008.03.008
Balbinot LF. Toxina Botulínica do tipo A. In: Maciel RN. Bruxismo. São Paulo: Artes Médicas; 2010. p. 525-34.
Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int. 2005;25(8):604-11. DOI: http://dx.doi.org/10.1007/s00296-004-0485-6
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
